• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

Correspondence on a € Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'

M Nikpour, B Teh, IP Wicks, M Pellegrini

Annals of the Rheumatic Diseases | BMJ PUBLISHING GROUP | Published : 2021

DOI: 10.1136/annrheumdis-2020-217827

University of Melbourne Researchers

Mandana Nikpour's Profile Picture
Mandana Nikpour Author

Benjamin Teh's Profile Picture
Benjamin Teh Author

Ian Wicks's Profile Picture
Ian Wicks Author

Related Projects (2)

Project icon

ADVANCEMENT OF A PERSONALISED APPROACH TO MINIMISING INFECTIVE COMPLICATIONS IN CANCER CARE

Managing infections in patients with cancer have become more difficult and unpredictable because of new generation cancer therapies. Measuri..

Project icon

IMPROVING OUTCOMES IN SYSTEMIC AUTOIMMUNE DISEASE

My research is focused on improving outcomes of autoimmune diseases scleroderma and lupus, that can affect multiple organs in the body, caus..

Grants

Awarded by National Health and Medical Research Council


Citation metrics

5Scopus
4Web of Science
7Dimensions

Keywords

32 Biomedical and Clinical Sciences
3 Good Health and Well Being
Coronaviruses
Rheumatology
Infectious Diseases
3202 Clinical Sciences
Life Sciences & Biomedicine
Lupus
Autoimmune Disease
Therapeutics
Emerging Infectious Diseases
Science & Technology

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224